Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00297362
What this trial is testing

The Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Cilag Pharmaceutica S.A.C.I., Greece 344
Not applicableStudy completedNCT03328195
What this trial is testing

Vielight Neuro RX Gamma - Feasibility Pilot

Who this might be right for
Alzheimer Disease
Vielight Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00104273
What this trial is testing

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
DementiaAlzheimer's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 376
Testing effectiveness (Phase 2)Study completedNCT00498602
What this trial is testing

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Post-approval studies (Phase 4)Study completedNCT02444637
What this trial is testing

Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD

Who this might be right for
Alzheimer DiseaseCVA (Cerebrovascular Accident)
National Neuroscience Institute 100
Testing effectiveness (Phase 2)Study completedNCT00244322
What this trial is testing

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 45
Post-approval studies (Phase 4)Looking for participantsNCT05924425
What this trial is testing

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

Who this might be right for
Alzheimer DiseaseInsomnia DisorderSleep
University Hospital, Montpellier 62
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Large-scale testing (Phase 3)Not Yet RecruitingNCT05809908
What this trial is testing

Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study

Who this might be right for
Alzheimer Disease
Cerecin 535
Large-scale testing (Phase 3)Study completedNCT00348140
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,468
Early research (Phase 1)Study completedNCT04715750
What this trial is testing

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear Palsy
Life Molecular Imaging GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00744978
What this trial is testing

Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 66
Testing effectiveness (Phase 2)Study completedNCT00381238
What this trial is testing

Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 33
Testing effectiveness (Phase 2)UnknownNCT00154635
What this trial is testing

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00265148
What this trial is testing

Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 80
Testing effectiveness (Phase 2)Ended earlyNCT01626391
What this trial is testing

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 9
Early research (Phase 1)Study completedNCT00675090
What this trial is testing

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 28
Early research (Phase 1)UnknownNCT05016427
What this trial is testing

Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
VTBIO Co. LTD 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Next Page